000 | 01943 a2200529 4500 | ||
---|---|---|---|
005 | 20250515091919.0 | ||
264 | 0 | _c20071212 | |
008 | 200712s 0 0 eng d | ||
022 | _a0008-5472 | ||
024 | 7 |
_a10.1158/0008-5472.CAN-07-0829 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRogers, Michael S | |
245 | 0 | 0 |
_aMutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth. _h[electronic resource] |
260 |
_bCancer research _cOct 2007 |
||
300 |
_a9980-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, Bacterial _xgenetics |
650 | 0 | 4 |
_aBacterial Toxins _xgenetics |
650 | 0 | 4 |
_aCarcinoma, Lewis Lung _xblood supply |
650 | 0 | 4 |
_aCell Growth Processes _xdrug effects |
650 | 0 | 4 |
_aCornea _xblood supply |
650 | 0 | 4 |
_aCorneal Neovascularization _xchemically induced |
650 | 0 | 4 |
_aEndothelial Cells _xcytology |
650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMembrane Proteins _xbiosynthesis |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMicrofilament Proteins |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aNeoplasm Proteins _xbiosynthesis |
650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 |
_aReceptors, Cell Surface _xbiosynthesis |
650 | 0 | 4 | _aReceptors, Peptide |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
700 | 1 | _aChristensen, Kenneth A | |
700 | 1 | _aBirsner, Amy E | |
700 | 1 | _aShort, Sarah M | |
700 | 1 | _aWigelsworth, Darran J | |
700 | 1 | _aCollier, R John | |
700 | 1 | _aD'Amato, Robert J | |
773 | 0 |
_tCancer research _gvol. 67 _gno. 20 _gp. 9980-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-07-0829 _zAvailable from publisher's website |
999 |
_c17463180 _d17463180 |